Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC)

Abstract Background Increasing evidence indicates that PIM1 is a potential prognostic marker and target for cancer treatment but its precise mechanisms of action remain to be determined in salivary adenoid cystic carcinoma (SACC). This study aims to decipher the prognostic and mechanistic role of PI...

Full description

Bibliographic Details
Main Authors: Jiajie Xu, Xin Zhu, Qingling Li, Chao Chen, Zhenying Guo, Zhuo Tan, Chuanming Zheng, Minghua Ge
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Cancer Cell International
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12935-018-0518-y
_version_ 1811334273178796032
author Jiajie Xu
Xin Zhu
Qingling Li
Chao Chen
Zhenying Guo
Zhuo Tan
Chuanming Zheng
Minghua Ge
author_facet Jiajie Xu
Xin Zhu
Qingling Li
Chao Chen
Zhenying Guo
Zhuo Tan
Chuanming Zheng
Minghua Ge
author_sort Jiajie Xu
collection DOAJ
description Abstract Background Increasing evidence indicates that PIM1 is a potential prognostic marker and target for cancer treatment but its precise mechanisms of action remain to be determined in salivary adenoid cystic carcinoma (SACC). This study aims to decipher the prognostic and mechanistic role of PIM1 in progression of SACC cells and tumor tissues. Methods A SACC cell line (ACC-M) was transfected with shRNA plasmids targeting the PIM1 gene. The expression levels of PIM1, RUNX3 and p21 were measured by quantitative real-time PCR and western blot. Subcellular translocalization of RUNX3 and p21 proteins was assessed using immunofluorescence, and cell cycle phase was quantified using flow cytometry. A total of 97 SACC patients were retrospectively analyzed by clinicopathologic characteristics and survival outcomes. Results After down-regulation of PIM1 in ACC-M cells, RUNX3 and p21 proteins were translocated from cytoplasm to nucleus, with a decrease of p21 expression and increase of G0/G1 phase cells. PIM1 and RUNX3 levels show a distinct covariance. PIM1 is associated with T-status, lymph node involvement, nerve invasion, and distant metastasis in SACC tissues. Patients with low PIM1 level had a better outcome than those with higher PIM1 level. Conclusions PIM1 is multifunctional in ACC-M cells and it serves as a neoteric therapeutic target and potential prognostic marker for SACC patients.
first_indexed 2024-04-13T17:06:13Z
format Article
id doaj.art-9a977615ca4e48acbbd4e863d94c9fe4
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-04-13T17:06:13Z
publishDate 2018-02-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-9a977615ca4e48acbbd4e863d94c9fe42022-12-22T02:38:28ZengBMCCancer Cell International1475-28672018-02-0118111110.1186/s12935-018-0518-yLoss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC)Jiajie Xu0Xin Zhu1Qingling Li2Chao Chen3Zhenying Guo4Zhuo Tan5Chuanming Zheng6Minghua Ge7Department of Head and Neck Surgery, Zhejiang Cancer HospitalZhejiang Cancer Research InstituteDepartment of Medical Oncology, Zhejiang Cancer HospitalDepartment of Head and Neck Surgery, Zhejiang Cancer HospitalDepartment of Pathology, Zhejiang Cancer HospitalDepartment of Head and Neck Surgery, Zhejiang Cancer HospitalDepartment of Head and Neck Surgery, Zhejiang Cancer HospitalDepartment of Head and Neck Surgery, Zhejiang Cancer HospitalAbstract Background Increasing evidence indicates that PIM1 is a potential prognostic marker and target for cancer treatment but its precise mechanisms of action remain to be determined in salivary adenoid cystic carcinoma (SACC). This study aims to decipher the prognostic and mechanistic role of PIM1 in progression of SACC cells and tumor tissues. Methods A SACC cell line (ACC-M) was transfected with shRNA plasmids targeting the PIM1 gene. The expression levels of PIM1, RUNX3 and p21 were measured by quantitative real-time PCR and western blot. Subcellular translocalization of RUNX3 and p21 proteins was assessed using immunofluorescence, and cell cycle phase was quantified using flow cytometry. A total of 97 SACC patients were retrospectively analyzed by clinicopathologic characteristics and survival outcomes. Results After down-regulation of PIM1 in ACC-M cells, RUNX3 and p21 proteins were translocated from cytoplasm to nucleus, with a decrease of p21 expression and increase of G0/G1 phase cells. PIM1 and RUNX3 levels show a distinct covariance. PIM1 is associated with T-status, lymph node involvement, nerve invasion, and distant metastasis in SACC tissues. Patients with low PIM1 level had a better outcome than those with higher PIM1 level. Conclusions PIM1 is multifunctional in ACC-M cells and it serves as a neoteric therapeutic target and potential prognostic marker for SACC patients.http://link.springer.com/article/10.1186/s12935-018-0518-ySalivary adenoid cystic carcinomaPIM1p21RUNX3Short hairpin RNA
spellingShingle Jiajie Xu
Xin Zhu
Qingling Li
Chao Chen
Zhenying Guo
Zhuo Tan
Chuanming Zheng
Minghua Ge
Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC)
Cancer Cell International
Salivary adenoid cystic carcinoma
PIM1
p21
RUNX3
Short hairpin RNA
title Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC)
title_full Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC)
title_fullStr Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC)
title_full_unstemmed Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC)
title_short Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC)
title_sort loss of pim1 correlates with progression and prognosis of salivary adenoid cystic carcinoma sacc
topic Salivary adenoid cystic carcinoma
PIM1
p21
RUNX3
Short hairpin RNA
url http://link.springer.com/article/10.1186/s12935-018-0518-y
work_keys_str_mv AT jiajiexu lossofpim1correlateswithprogressionandprognosisofsalivaryadenoidcysticcarcinomasacc
AT xinzhu lossofpim1correlateswithprogressionandprognosisofsalivaryadenoidcysticcarcinomasacc
AT qinglingli lossofpim1correlateswithprogressionandprognosisofsalivaryadenoidcysticcarcinomasacc
AT chaochen lossofpim1correlateswithprogressionandprognosisofsalivaryadenoidcysticcarcinomasacc
AT zhenyingguo lossofpim1correlateswithprogressionandprognosisofsalivaryadenoidcysticcarcinomasacc
AT zhuotan lossofpim1correlateswithprogressionandprognosisofsalivaryadenoidcysticcarcinomasacc
AT chuanmingzheng lossofpim1correlateswithprogressionandprognosisofsalivaryadenoidcysticcarcinomasacc
AT minghuage lossofpim1correlateswithprogressionandprognosisofsalivaryadenoidcysticcarcinomasacc